Mitoxantrone Completed Phase 1 / 2 Trials for Malignancies / Castrate-resistant Prostate Cancer (CRPC) / Mestastatic Prostate Cancer / Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00059631Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone